References
- Ludwig H, Kumpan W, Sinzinger H. Radiography and bone scintigraphy in multiple myeloma: a comparative analysis. Br J Radiol 1982;55(651):173-81. (Level II/III evidence)
- Woolfenden JM, Pitt MJ, Durie BGM, et al. Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology 1980;134:723-8. (Level III evidence)
- Pace Leonardo, Catalano L, Del Vecchio S, et al. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up. Eur J Nucl Med 2001;28:304-12. (Level III evidence)
- Svaldi M, Tappa C, Gebert U, et al. Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation. Ann Hematol 2001;80(7):393-7. (Level II/III evidence)
- Orchard K, Barrington S, Buscombe J, et al. Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma. Br J Haematology 2002;117:133-5. (Level IV evidence)
- Lecouvet FE, Vande Berg BC, Malghem J, et al. Magnetic resonance and computed tomography imaging in multiple myeloma. Seminars in Musculoskeletal Radiology 2001;5(1):43-55.
- Lecouvet FE, Malghem J, Michaux L, et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematology 1999;106:35-9. (Level II evidence). Click here to view reference
- Mahnken AH, Wildberger JE, Gehbauer G, et al. Multidetector CT of the Spine in Multiple Myeloma: Comparison with MR Imaging and Radiography. AJR 2002;178:1429-36 (Level III evidence)
- Dimopoulos M, Terpos E, Comenzo RL, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia. 2009. (Guidelines) Click here to view guidelines
- Schreiman JS, McLeod RA, Kyle RA, Beabout JW. Multiple myeloma: evaluation by CT. Radiology. 1985; 154: 483-6. (Level III evidence)
- Mahnken AH, Wildberger JE, Gehbauer G, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. Ajr. 2002; 178: 1429-36. (Level III evidence)
- Ghanem N, Lohrmann C, Engelhardt M, et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. European radiology. 2006; 16: 1005-14. (Level III evidence)
- Lecouvet FE, Malghem J, Michaux L, et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. British journal of haematology. 1999; 106: 35-9. (Level II evidence)
- Baur-Melnyk A, Buhmann S, Becker C, et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. Ajr. 2008; 190: 1097-104. (Level III evidence)
- Baur-Melnyk A, Buhmann S, Durr HR, et al. Role of MRI for the diagnosis and prognosis of multiple myeloma. European journal of radiology. 2005; 55: 56-63. (Review article) Click here to view guidelines
- Walker R, Barlogie B, Haessler J, et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol. 2007; 25: 1121-8. (Level III evidence)
- Balleari E, Villa G, Garre S, et al. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease. Haematologica. 2001; 86: 78-84. (Level II evidence)
- Bredella MA, Steinbach L, Caputo G, et al. Value of FDG PET in the assessment of patients with multiple myeloma. Ajr. 2005; 184: 1199-204. (Level III evidence)
- Mirzaei S, Filipits M, Keck A, et al. Comparison of Technetium-99m-MIBI imaging with MRI for detection of spine involvement in patients with multiple myeloma. BMC nuclear medicine. 2003; 3: 2. (Level III evidence)
File Formats
Some documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.
